Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-09-27 Cantley Lewis Clayton Jr. Director Sale −627 $54.15 $34K 109,659
2016-09-27 Cantley Lewis Clayton Jr. Director Sale −625 $54.15 $34K 109,693
2016-09-20 Biller Scott Chief Scientific Officer Sale −5,000 $50.00 $250K 21,000
2016-09-20 Hirsch Andrew Chief Financial Officer Grant or award · Stock option (right to buy) +125,000 125,000
2016-08-30 Cantley Lewis Clayton Jr. Director Sale −627 $36.81 $23K 110,286
2016-08-30 Cantley Lewis Clayton Jr. Director Sale −625 $36.81 $23K 110,318
2016-08-29 Cantley Lewis Clayton Jr. Director Sale −627 $37.81 $24K 110,913
2016-08-29 Cantley Lewis Clayton Jr. Director Sale −625 $37.81 $24K 110,943
2016-08-08 NELSEN ROBERT Director Other acquisition +36,152 109,230
2016-06-30 NELSEN ROBERT Director Other acquisition +25,412 73,078

Page 80 of 80 · 1,590 trades